DeepScan Diagnostics

DeepScan Diagnostics

Private
HelsinkiHealthcare & Life Scienceshttps://www.deepscandx.com/

Last Round

Seed

Apr 21, 2026

Total Funding Raised

$6.01M

Momentum Score

75 /100

Company Overview

DeepScan Diagnostics is a veterinary biotechnology company that provides diagnostic solutions for veterinarians, enabling early detection of canine cancer and other diseases through advanced CFD® biomarker testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

veterinary diagnosticscanine liquid biopsycfDNA testingcirculating cell-free DNAcfDNAcanine cancer detectiondog cancer testveterinary biotechpet diagnosticsbiomarker testcanine disease monitoringveterinary lab services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DeepScan Diagnostics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DeepScan Diagnostics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedApr 21, 2026
GrantFeb 3, 2025
Pre SeedNov 25, 2024
GrantFeb 7, 2024

Key People

Founding team and executive leadership

William von der Pahlen

Co-founder, CEO

Founding Team

DeepScan Diagnostics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    $4M raised, led by Calm/Storm Ventures

  • Apr 6, 2026

    Monthly visitors increased 115% MoM, reaching 3.7K.

DeepScan Diagnostics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DeepScan Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DeepScan Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersHelsinki
Employee Range16
Year Founded2022
Last FundingApr 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.